Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Cash from Operations (2016 - 2023)

Historic Cash from Operations for Mesoblast (MESO) over the last 8 years, with Q2 2023 value amounting to -$16.3 million.

  • Mesoblast's Cash from Operations fell 1715.85% to -$16.3 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$63.3 million, marking a year-over-year decrease of 11531.79%. This contributed to the annual value of -$50.0 million for FY2025, which is 318.21% down from last year.
  • Mesoblast's Cash from Operations amounted to -$16.3 million in Q2 2023, which was down 1715.85% from -$77.7 million recorded in Q1 2023.
  • Over the past 5 years, Mesoblast's Cash from Operations peaked at $21.2 million during Q1 2019, and registered a low of -$96.5 million during Q2 2019.
  • For the 5-year period, Mesoblast's Cash from Operations averaged around -$17.8 million, with its median value being -$15.9 million (2022).
  • Its Cash from Operations has fluctuated over the past 5 years, first plummeted by 239924.81% in 2020, then skyrocketed by 19031.23% in 2022.
  • Over the past 5 years, Mesoblast's Cash from Operations (Quarter) stood at $1.3 million in 2019, then plummeted by 2399.25% to -$30.6 million in 2020, then surged by 40.42% to -$18.2 million in 2021, then skyrocketed by 190.31% to $16.5 million in 2022, then plummeted by 198.93% to -$16.3 million in 2023.
  • Its Cash from Operations was -$16.3 million in Q2 2023, compared to -$77.7 million in Q1 2023 and $16.5 million in Q4 2022.